Hematological and Coagulation Factors in Term and Preterm Newborns of Mothers With Pre-eclampsia
Abstract
Objective: Pre-eclampsia (preE) is pregnancy-induced hypertension affecting a significant proportion of
pregnant women worldwide and can cause detrimental effects on the mother and newborn. Recognition of
contributing factors of health in neonates with pre-eclamptic mothers is important to reduce the burden of
the problem. The aim of the study was to determine the hematologic and coagulation factors in term and
preterm neonates born to mothers with pre-eclampsia.
Method and Materials: In this observational cross-sectional comparative study, 104 neonates born to
mothers with pre-eclampsia in Imam-Hossein Hospital from 2018 to 2021 were enrolled. The neonates
were divided into term and preterm groups according to the gestational age of the mothers. Maternal and
fetal parameters of neonates were collected. The hematologic and coagulation factors were recorded and
compared.
Results: The finding of the study demonstrated that the mean leukocyte ( P=0.030), hemoglobin ( P=0.0001),
and platelet ( P=0.0001) were significantly higher in term neonates. The mean PT ( P=0.003), PPT ( P=0.001),
and INR ( P=0.003) were significantly higher in preterm cases.
Conclusion: Totally, according to the obtained results it may be concluded that CBC indexes and
coagulopathy in term and preterm neonates born to mothers with pre-eclampsia are significantly different.
2. Un Nisa S, Shaikh AAKumar R. Maternal and Fetal Outcomes of Pregnancy-related Hypertensive Disorders in a Tertiary Care Hospital in Sukkur, Pakistan. Cureus. 2019;11(8):e5507.
3. El Sayed MAAhmed A. Assessment of the hematological profile in neonates borne to sever pre eclamptic mothers (single center study). Int J Pregn & Chi Birth. 2018;4(6):214-18.
4. Lin S, Leonard D, Co MA, Mukhopadhyay D, Giri B, Perger L, et al. Pre-eclampsia has an adverse impact on maternal and fetal health. Translational Research. 2015;165(4):449-63.
5. Marins LR, Anizelli LB, Romanowski MDSarquis AL. How does preeclampsia affect neonates? Highlights in the disease’s immunity. J Matern Fetal Neonatal Med. 2019;32(7):1205-12.
6. Nelson SMGreer IA. Hypertensive disorders of pregnancy: preventative-, immediate- and long-term management. Expert Rev Pharmacoecon Outcomes Res. 2006;6(5):541-54.
7. Boddapati A, Inuganti Venkata R, Riyaz P, B.V VDeepak V. Hematological and Biochemical Abnormalities in Pregnancy-Induced Hypertension. Journal of Clinical and Basic Research. 2022;6(2):12-20.
8. Bayoumi MAA, Ali AAH, Hamad SG, Ali AAM, Elmalik EE, Elkalaf M, et al. Effect of Maternal Preeclampsia on Hematological Profile of Newborns in Qatar. Biomed Res Int. 2020;2020:7953289.
9. Kattah AGGarovic VD. The management of hypertension in pregnancy. Adv Chronic Kidney Dis. 2013;20(3):229-39.
10. Rocha G. Consequences of early-onset preeclampsia on neonatal morbidity and mortality. Minerva Pediatr (Torino). 2023;75(1):87-97.
11. Gruslin ALemyre B. Pre-eclampsia: fetal assessment and neonatal outcomes. Best Pract Res Clin Obstet Gynaecol. 2011;25(4):491-507.
12. Beiner ME, Simchen MJ, Sivan E, Chetrit A, Kuint JSchiff E. Risk factors for neonatal thrombocytopenia in preterm infants. Am J Perinatol. 2003;20(1):49-54.
13. Backes CH, Markham K, Moorehead P, Cordero L, Nankervis CAGiannone PJ. Maternal preeclampsia and neonatal outcomes. J Pregnancy. 2011;2011:214365.
14. McCrae KR. Thrombocytopenia in pregnancy. Hematology Am Soc Hematol Educ Program. 2010;2010(1):397-402.
15. Mosayebi Z, Nariman S, Hosseini LMovahedian AH. Evaluation of laboratory disorders in admitted neonates in NICU who were born to preeclamptic mothers. 2013.
16. Bolat A, Gursel O, Kurekci E, Atay AOzcan O. Blood parameters changes in cord blood of newborns of hypertensive mothers. Eur J Pediatr. 2013;172(11):1501-9.
Files | ||
Issue | Vol 5, No 4 (2022) | |
Section | Original Article | |
DOI | https://doi.org/10.18502/igj.v5i4.16179 | |
Keywords | ||
Pre-eclampsia Neonatal Preterm Hematologic Factors |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |